Fungal infection treatment and resistance study

This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.

This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.

This study looks at how common antifungal resistance is in fungal skin infections. If you join, doctors will check the type of fungus and see if it resists standard treatments, which may help guide better care.

This study looks at Candida infections that are hard to treat, especially when the body's defenses are weak or after medical procedures. It aims to understand why some Candida become resistant to antifungal medicines and form protective layers called biofilms.

This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.

This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.